Pediatric anthrax clinical management: executive summary.
John S
JS
Bradley
Georgina
G
Peacock
Steven E
SE
Krug
William A
WA
Bower
Amanda C
AC
Cohn
Dana
D
Meaney-Delman
Andrew T
AT
Pavia
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000881:Anthrax / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy* / Q000635:transmission; D022122:Anthrax Vaccines / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000942:Antigens, Bacterial; D000992:Antitoxins / Q000627:therapeutic use; D001408:Bacillus anthracis; D001427:Bacterial Toxins / Q000037:antagonists & inhibitors; D054045:Biological Warfare Agents; D023482:Bioterrorism; D001942:Breast Feeding; D002648:Child; D002675:Child, Preschool; D004189:Disaster Planning / Q000458:organization & administration*; D005260:Female; D066275:Health Information Exchange; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D014481:United States; D055815:Young Adult
D000305:Adrenal Cortex Hormones; D022122:Anthrax Vaccines; D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000942:Antigens, Bacterial; D000992:Antitoxins; D001427:Bacterial Toxins; D054045:Biological Warfare Agents; D016756:Immunoglobulins, Intravenous; C030325:anthrax toxin; C542124:raxibacumab